Cells lining the lung airways have their own body clock which is the time-keeper for lung inflammation. The findings open up new ways to treat lung disease like asthma and pneumonia.
A new study from researchers at UT-Southwestern found that antiviral molecules known as type I interferons (IFNs) block the development of allergy- and asthma-driving Th2 cells.
Infants exposed to rodent and pet dander, roach allergens and a wide variety of household bacteria in the first year of life appear less likely to suffer from allergies, wheezing and asthma.
Reminders prompting asthma patients to take their control inhalers if they miss a dose significantly improve medication adherence. Patients receiving reminders took a greater percentage of their prescribed doses compared patients who did not have reminders (73% vs. 46%).
In adults with persistent asthma, elevated blood eosinophil levels may be able to predict which individuals are at increased risk for exacerbations.
As healthcare costs and hospital readmissions continue to rise, the field of respiratory care has begun to embrace the advantages of home care solutions for chronic lung patients.
As the number of chronic lung patients continues to grow, today’s aerosol therapy products are providing high-quality, cost-efficient medication delivery.
Children who are exposed in utero to high levels of particulate air pollution during the second trimester of pregnancy may be at greater risk of developing asthma in early childhood, according to a new study.
Blocking a protein called thymic stromal lymphopoietin (TSLP), which causes inflammation, both alleviates baseline inflammation and provides resistance to allergens for those with mild allergic asthma.
Young adults (age 18-25) living with asthma need to be provided with the tools to self-manage their disease and reduce their risk of exacerbation and hospital admission.